The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Foreign investors buy UK firms at fastest pace since 2007

Tue, 24th Mar 2015 15:02

* UK acquisitions by foreign buyers total $48 bln year todate

* Highest since 2007 even if bid for O2 is excluded

* Weaker pound, better growth lure U.S. buyers

* Political uncertainty fails to dampen appetite

By Francesco Canepa

LONDON, March 24 (Reuters) - Foreign investors are snappingup British companies at the fastest pace in eight years as anunusual combination of stronger economic growth and a weakcurrency lures U.S. buyers despite political uncertainty.

Investors appear relatively unconcerned about the risk ofinstability after a general election on May 7 or doubts aboutBritain's future in the European Union. Even excluding a $15billion bid by Hutchison Whampoa for O2's UKoperations, inbound mergers & acquisitions activity so far thisyear is at its highest since 2007, Thomson Reuters data showed.

The total value of bids and completed deals in the period is$33 billion, including debt taken on by buyers. The figure risesto $48 billion when Hong Kong-based Hutchison's bid for themobile phone operator is included.

This reverses a seven-year decline and contrasts to a fallin inbound M&A activity in the euro zone and United States.

It also confounds expectations of dwindling M&A before theelections, in which opinion polls suggest no party will win amajority. This raises the possibility of an unstable coalitionor minority government propped up by smaller parties such as thepro-independence Scottish nationalists.

On top of this, the ruling Conservatives have promised areferendum within two years on whether Britain should leave theEU, should they be re-elected.

Many British business leaders are worried by the prospect.The chairman of insurer Standard Life said on Tuesday it would be disastrous for the country and London's financialcentre if Britain were to leave the EU single market.

However, bankers say U.S. investors are being attracted bysterling's weakness against the dollar - which makes Britishtargets cheaper for them - even though the economy is buoyant.

"The UK is at the forefront because the economy, aside fromthe uncertainty around the elections, is an attractive marketwith good growth dynamics," said Dirk Albersmeier, co-head ofM&A for Europe, the Middle East and Africa at JP Morgan.

With the Bank of England expected to keep interest ratesultra low for another year, the pound has fallen 13 percentagainst the dollar since July and is now hovering just above afive-year low. At the same time, official economic growthforecasts were upgraded last week to 2.5 percent this year and2.3 percent in 2016.

VALUATIONS BOOST

Valuations have provided a further boost. UK shares trade ata 10 percent discount to their U.S. counterparts based on theratio between price and expected earnings, Datastream datashowed.

Inbound M&A activity in Britain had been falling since 2007,data from the Office for National Statistics showed, partly dueto the pound's recovery against the euro since 2009.

This year's increase has been driven by 73 small andmid-sized acquisitions by U.S. buyers, such as drinks can makerBall Corp's $8.6 billion move for rival Rexam and a $2.8 billion bid by Verisk Analytics for energyconsultancy Wood Mackenzie.

These deals have more than offset a drying up of last year'sstream of large bids which were partly motivated by lowercorporate tax rates in Britain than in the United States, suchas Pfizer's abandoned attempt to buy fellowpharmaceutical group AstraZeneca.

Such bids have been curbed by a tightening of U.S. tax rulesand worries about possible fiscal changes in Britain after theelections.

As the economic recovery picks up pace, sectors which dependon growth are playing a larger role in M&A, joining defensivesectors such as healthcare and telecommunications, media andtechnology (TMT), where activity has been high for some time.

Aside from the telecoms and materials sectors, where theamount was skewed by the O2 and Rexam bids, inbound M&A activitythis year has been at its highest in the consumer goods sectorand industrial sectors, the data showed.

This marks a change from the previous year, when real estatedominated, with financials and high tech a distant second andthird, respectively.

"Activity is likely to be more broad-based than last year,"said Wilhelm Schulz, head of M&A for Europe, the Middle East andAfrica at Citi. "I expect this year we will see activity inhealthcare, TMT, industrials, chemicals and consumer products." (Additional reporting by Anjuli Davies and Freya Berry; editingby David Stamp)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.